市場調査レポート

商品コード

1653943

バイオバンク市場規模、シェア、成長分析：製品・サービス別、バイオバンクの種類別、サンプルタイプ別、保管タイプ別、所有者別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Biobanking Market Size, Share, and Growth Analysis, By Product &Service, By Biobanks Type, By Sample Type, By Storage Type, By Ownership, By Application, By End user, By Region - Industry Forecast 2025-2032

出版日: 2025年02月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バイオバンク市場規模は2023年に720億米ドルと評価され、2024年の769億米ドルから2032年には1,301億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.8%で成長する見通しです。

バイオバンク市場は、従来のバイオバンクを革新的な仮想プラットフォームへと進化させる先端技術、データ分析、自動化によって大きな成長を遂げています。この変革は、疾患特異的、ヒトベース、組織バンク、血液バンクなど、さまざまなタイプのバイオバンクに対応し、市場力学を強化しています。変性疾患の有病率の増加は、バイオバンクサービスの需要をさらに高める。バーチャルバイオバンクへのシフトは、プロセスを合理化し、ターンアラウンドタイムを短縮し、研究者がより効率的に作業できるようにし、最終的にバイオバンクの収益創出を強化します。さらに、ソフトウェア会社はバイオバンクプロセスを最適化するソリューションを積極的に開発しており、バーチャルシステムの普及を支えています。このような技術と需要の融合により、バイオバンク市場は今後数年間で大きく成長するものと思われます。

市場概要
装置
- 保管設備
- サンプル分析装置
- サンプル処理装置
- サンプル輸送装置
消耗品
- ストレージ消耗品
- 分析消耗品
- 加工消耗品
- コレクション消耗品
サービス
- ストレージサービス
- 処理サービス
- 輸送サービス
- 供給サービス
ソフトウェア

バイオバンク市場規模：バイオバンクの種類別& CAGR（2025-2032）

市場概要
物理的/リアルなバイオバンク
組織バイオバンク
人口ベースのバイオバンク
遺伝（DNA/RNA）
疾患ベースのバイオバンク
バーチャルバイオバンク

バイオバンク市場規模：サンプルタイプ別& CAGR（2025-2032）

市場概要
血液製品
人間の組織
細胞株
核酸
体液
人間の排泄物

バイオバンク市場規模：ストレージタイプ別& CAGR（2025-2032）

市場概要
手動ストレージ
自動ストレージ

バイオバンク市場規模：所有権別& CAGR（2025-2032）

市場概要
大学
国/地域機関
非営利団体
民間団体

バイオバンク市場規模：用途別& CAGR（2025-2032）

市場概要
再生医療
ライフサイエンス調査
臨床調査

バイオバンク市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
製薬
バイオテクノロジー企業とCRO
アカデミック
調査機関
病院

バイオバンク市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Thermo Fisher Scientific Inc.（United States）
Merck KGaA（Germany）
QIAGEN N.V.（Netherlands）
Hamilton Company（United States）
Tecan Trading AG（Switzerland）
Becton, Dickinson and Company（BD）（United States）
Lonza Group AG（Switzerland）
Charles River Laboratories International, Inc.（United States）
BioLife Solutions, Inc.（United States）
Brooks Automation, Inc.（United States）
Greiner Bio-One International GmbH（Austria）
STEMCELL Technologies Inc.（Canada）
Chart Industries, Inc.（United States）
BioIVT（United States）
Firalis S.A.（France）
Celltex Therapeutics Corporation（United States）
Sigma-Aldrich Corporation（United States）
Hope Biosciences（United States）
54Gene（Nigeria）

結論と提言

Product Code: SQMIG35H2200

Biobanking Market size was valued at USD 72.0 billion in 2023 and is poised to grow from USD 76.9 billion in 2024 to USD 130.16 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).

The Biobanking Market is experiencing significant growth, fueled by advanced technologies, data analytics, and automation that are evolving traditional biobanks into innovative virtual platforms. This transformation accommodates various types of biobanks, including disease-specific, human-based, tissue, and blood banks, which collectively strengthen market dynamics. Increasing prevalence of degenerative diseases further enhances the demand for biobanking services. The shift towards virtual biobanking streamlines processes, reducing turnaround times and allowing researchers to work more efficiently, ultimately enhancing revenue generation for biobanks. Additionally, software companies are actively developing solutions to optimize the biobanking process, supporting the widespread adoption of virtual systems. This convergence of technology and demand positions the Biobanking Market for substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biobanking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biobanking Market Segments Analysis

Global Biobanking Market is segmented by Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user and region. Based on Product &Service, the market is segmented into Equipment, Consumables, Services and Software. Based on Biobanks Type, the market is segmented into Physical/Real Biobanks, Tissue Biobanks, Population Based Biobanks, Genetic (DNA/RNA), Disease Based Biobanks and Virtual Biobanks. Based on Sample Type, the market is segmented into Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids and Human Waste Products. Based on Storage Type, the market is segmented into Manual Storage and Automated Storage. Based on Ownership, the market is segmented into Universities, National/Regional Agencies, Non-Profit Organizations and Private Organizations. Based on Application, the market is segmented into Regenerative Medicine, Life Science Research and Clinical Research. Based on End user, the market is segmented into Pharmaceutical, Biotechnology Companies and CROs, Academic, Research Institutes and Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biobanking Market

One of the primary catalysts for the biobanking market is the swift advancement in genomics research and the rise of personalized medicine. As researchers deepen their comprehension of genetic markers and the intricacies of disease progression, the necessity for biobanks that preserve high-quality biosamples for genomic studies becomes increasingly prominent. These biosamples are crucial for the development of targeted therapies, which are essential in the realm of personalized medicine. Consequently, biobanking plays a pivotal role in shaping the future of healthcare, highlighting its significance in supporting cutting-edge research and innovative treatment strategies tailored to individual patients.

Restraints in the Biobanking Market

The biobanking market faces significant constraints stemming from ethical and legal considerations related to the collection, storage, and utilization of biospecimens. Key concerns include patient privacy, the processes of obtaining informed consent, and the potential for sensitive information to be misappropriated. These challenges create obstacles for biobanks as they strive to navigate regulatory requirements while maintaining public trust. The necessity to balance operational goals with the protection of individual rights and data confidentiality can hinder the growth and development of biobanks, as they must work within a complex legal landscape while ensuring ethical standards are upheld.

Market Trends of the Biobanking Market

The biobanking market is witnessing a significant trend towards the integration of artificial intelligence (AI) and big data analytics, revolutionizing how biosamples are managed and utilized. This technological advancement enhances specimen tracking, streamlines data management, and ensures superior quality in specimen storage. By employing AI-driven analytics, biobanks can sift through extensive biosample datasets to uncover valuable patterns and insights, thereby accelerating biomarker discovery and expediting drug development timelines. As researchers increasingly leverage these tools, the biobanking sector is positioned to unlock new opportunities in personalized medicine and innovation, ultimately driving growth and evolution within the healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Biobanking Market Size by Product &Service & CAGR (2025-2032)

Market Overview
Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
Services
- Storage Services
- Processing Services
- Transport Services
- Supply Services
Software

Global Biobanking Market Size by Biobanks Type & CAGR (2025-2032)

Market Overview
Physical/Real Biobanks
Tissue Biobanks
Population Based Biobanks
Genetic (DNA/RNA)
Disease Based Biobanks
Virtual Biobanks

Global Biobanking Market Size by Sample Type & CAGR (2025-2032)

Market Overview
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products

Global Biobanking Market Size by Storage Type & CAGR (2025-2032)

Market Overview
Manual Storage
Automated Storage

Global Biobanking Market Size by Ownership & CAGR (2025-2032)

Market Overview
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations

Global Biobanking Market Size by Application & CAGR (2025-2032)

Market Overview
Regenerative Medicine
Life Science Research
Clinical Research

Global Biobanking Market Size by End user & CAGR (2025-2032)

Market Overview
Pharmaceutical
Biotechnology Companies and CROs
Academic
Research Institutes
Hospitals

Global Biobanking Market Size & CAGR (2025-2032)

North America (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- US
- Canada
Europe (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Trading AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brooks Automation, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greiner Bio-One International GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioIVT (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Firalis S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltex Therapeutics Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hope Biosciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
54Gene (Nigeria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments